The company's new Sugar Land, TX distribution facility is the second for Quva, as it expands its 503B forward distribution capabilities and adds another 20,000 sq. ft. of distribution capacity. The ...

August 24, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding pharmacy services led by two experienced industry executives, announces it has completed the acquisition ...

SUGAR LAND, Texas, Nov. 11, 2019 /PRNewswire/ -- QuVa Pharma, Inc. announced today that is has launched a new flag label design for its syringe product portfolio of compounded sterile products (CSPs) ...

QuVa Pharma, a provider of essential medications in ready-to-administer injectable formats to hospitals, has secured a $275 million senior debt facility. Goldman Sachs was the lead backer with ...

SUGAR LAND, Texas, Dec. 9, 2019 /PRNewswire/ -- QuVa Pharma, Inc. today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia ...

Equity Commitment from Bain Capital Private Equity; Experienced Management Team from JHP Pharmaceuticals — August 24, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding ...

Sugar Land, TX– November 2, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding pharmacy services, has acquired the assets of Unique Pharmaceuticals, Ltd., including its ...

QuVa Pharma completed a $275 million financing round May 6. Goldman Sachs Private Credit Investing led the financing round, which also included Owl Rock Capital Partners. QuVa is an FDA-registered ...

QuVa Pharma, a provider of sterile compounding pharmacy services, said today it expects to hire more than 100 people to staff a New Jersey biotech facility that the company agreed to buy for an ...

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. Quva’s software platform streamlines the way alternative investment ...

QuVa Pharma Inc. announced Thursday that it has agreed to acquire a biotech pharmaceutical facility in New Jersey.The Sugar Land, Texas-based sterile compounding pharmacy services company said in a ...